The drug development landscape in Parkinson's

OxTalks is Changing

During Michaelmas Term, OxTalks will be moving to a new platform (full details are available on the Staff Gateway).
For now, continue using the current page and event submission process (freeze period dates to be advised).

If you have any questions, please contact halo@digital.ox.ac.uk

The drug development landscape in Parkinson's

This event will be held in person. Please note slightly the later start time of 12:15pm

Originally a biochemist, Dr Kevin McFarthing’s career included R&D leadership positions in life sciences research products with Amersham, diagnostics with Serono and consumer healthcare with Reckitt Benckiser. He curates the Parkinson’s Hope List (bit.ly/ParkinsonsHopeList), a database of potential therapies in research and clinical stages. Kevin was diagnosed with Parkinson’s in 2012 at the age of 55.

Date: 24 May 2022, 12:15
Venue:
Dorothy Crowfoot Hodgkin Building
off South Parks Road OX1 3QU
See location on maps.ox

Details: This seminar will be held in the Dorothy Crowfoot Hodgkin Building (Phase II Biochemistry), Ground Floor Seminar Room (20-140). Email: opdc.administrator@dpag.ox.ac.uk for more details.
Speaker: Dr Kevin McFarthing (Research Advisor, Parkinson’s UK Oxford Branch)
Organising department: Department of Physiology, Anatomy and Genetics (DPAG)
Organiser: Lorraine Dyson (University of Oxford)
Organiser contact email address: opdc.administrator@dpag.ox.ac.uk
Host: Professor Richard Wade-Martins (Professor of Molecular Neuroscience, University of Oxford)
Part of: OPDC Seminar Series (DPAG)
Booking required?: Not required
Audience: Members of the University only
Editors: Samuel Press, Lorraine Dyson